Aricept · Taxotere · Protonix · Levaquin · Cozaar · Hyzaar · Gemzar
Actos · Oxycontin · Plavix · Seroquel · Zyprexa · Xalatan
Avandia · Diovan · Lexapro · Singulair · Viagra · Geodon · Zometa · Detrol · Evista · Lovenox
Cymbalta · Iressa · Abreva · Rescriptor · Humalog · Byetta · Viracept
Abilify · Nexium · Micardis · Celebrex · Hectorol · Copaxone
Disclaimer: The descriptions presented here are based on information available at the time of catalog preparation. FOI Services, Inc. does not accept responsibility for any errors or omissions. This catalog is intended only as a guide; further verification of these data is necessary before accepting the information as correct. Companies relying on the information do so at their own risk. Documents supplied as a result of any orders from this catalog will be faithful copies of the originals supplied by the U.S. government.
Copyright © 2010 by FOI Services, Inc. All rights reserved. None of the content of this catalog may be reproduced without an express acknowledgement of FOI Services, Inc. as the original author.
Interested in ALL the drugs scheduled to fall off patent? Have a look at FOI Services' 2010 Edition of the bestselling book Drugs Under Patent, the comprehensive guide to products affected by the Waxman-Hatch Act.
In these listings, we've concentrated on giving you the information of most interest to those interested in investigating potential generic market entry. For most of the drugs listed (and many others), we have even more information. To find everything we have available for a product, use the home page search box to enter the drug name. Depending on the drug, you may find additional supplements and labeling changes, inspection reports, correspondence, Warning Letters, and other unpublished documents.
FOI Services produces teleconferences on a variety of regulatory topics, many of which are related to the drug industry. Click here to view a list of our upcoming presentations. Information for ordering audio recordings of past presentations is also available.
FOI can prepare a customized Drug Adverse Event report for you for any drug included in FDA's files back to 1969. Delivered in an Access database, you can manipulate the data to suit your research needs. See a sample here.
Each week, FOI Services offers a new free document with information of interest to FDA-regulated firms. Here's a sample for you to download free -- check back every week.
Office of Inspector General: The Food and Drug Administrations Generic Drug Review Process, June 2008.